Renaisa

Renaisa is a direct-to-consumer skincare label that concentrates on science-backed serums, barrier-support moisturizers and targeted treatment capsules; everything is sold exclusively through renaisa.com. Price points sit in the mid-range tier, with most 30 ml serums between $38-$58 and treatment sets capped at $120. The site ships worldwide from U.S. fulfillment centers and offers refill pouches that knock 15% off the original bottle price. The brand formulates without fragrance, essential oils or silicones and publishes third-party lab data for irritation testing and active potency on every product page. Its “ChronoRelease” encapsulation technology—visible as micro-beads that dissolve on contact—allows 12-hour staggered delivery of retinaldehyde and vitamin C in the flagship Night Shift serum, the line’s best-selling SKU. Renaisa also keeps production runs below 1,000 units to stamp each box with a batch code that links to a publicly accessible stability report. Customers are 25-40-year-old professionals who track ingredient research on Reddit skincare threads and want clinical-grade results without dermatologist-office mark-ups. They value transparency over influencer hype, often cross-checking INCI lists and pH metrics before purchasing, and appreciate the brand’s carbon-neutral shipping and optional aluminum cap refills that reduce plastic by 60%. Renaisa competes with mid-priced “clinical-clean” brands that straddle drugstore and prestige shelves, differentiating itself by publishing raw lab data, eliminating all sensitizing additives and limiting batch sizes to guarantee freshness. Where rivals rely on retail margins and frequent promo cycles, Renaisa’s online-only model funds smaller, evidence-driven launches and keeps unit costs lower than comparable dermatologist-distributed formulas.